Q9UEW8
Gene name |
STK39 (SPAK) |
Protein name |
STE20/SPS1-related proline-alanine-rich protein kinase |
Names |
Ste-20-related kinase, DCHT, Serine/threonine-protein kinase 39 |
Species |
Homo sapiens (Human) |
KEGG Pathway |
hsa:27347 |
EC number |
2.7.11.1: Protein-serine/threonine kinases |
Protein Class |
|

Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
209-237 (Activation loop from InterPro)
Target domain |
63-337 (Protein kinase domain) |
Relief mechanism |
|
Assay |
|
Autoinhibited structure

Activated structure

2 structures for Q9UEW8
Entry ID | Method | Resolution | Chain | Position | Source |
---|---|---|---|---|---|
7O86 | X-ray | 173 A | A/B | 441-545 | PDB |
AF-Q9UEW8-F1 | Predicted | AlphaFoldDB |
319 variants for Q9UEW8
Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
---|---|---|---|---|---|
rs774637794 CA1949290 |
2 | A>E | No |
ClinGen ExAC gnomAD |
|
rs774637794 CA349253877 |
2 | A>V | No |
ClinGen ExAC gnomAD |
|
rs1238134942 CA349253870 |
3 | E>D | No |
ClinGen TOPMed gnomAD |
|
CA349253866 rs1376804558 |
4 | P>S | No |
ClinGen gnomAD |
|
rs573383297 CA1949284 |
6 | G>A | No |
ClinGen 1000Genomes ExAC TOPMed gnomAD |
|
rs747014948 CA1949286 |
6 | G>R | No |
ClinGen ExAC TOPMed gnomAD |
|
CA1949285 rs747014948 |
6 | G>S | No |
ClinGen ExAC TOPMed gnomAD |
|
rs771911950 CA1949283 |
8 | P>L | No |
ClinGen ExAC gnomAD |
|
rs1196032004 CA349253838 |
9 | V>L | No |
ClinGen TOPMed |
|
CA1949279 rs748780606 |
12 | Q>H | No |
ClinGen ExAC gnomAD |
|
CA1949280 rs553432668 |
12 | Q>L | No |
ClinGen 1000Genomes ExAC gnomAD |
|
rs1161078101 CA349253780 |
13 | L>V | No |
ClinGen TOPMed |
|
CA1949278 rs777494391 |
14 | P>S | No |
ClinGen ExAC gnomAD |
|
CA349253752 rs1377908701 |
15 | Q>E | No |
ClinGen gnomAD |
|
RCV000332811 rs886043154 |
19 | P>missing | No |
ClinVar dbSNP |
|
rs767710354 CA1949274 |
21 | T>I | No |
ClinGen ExAC TOPMed gnomAD |
|
rs767710354 CA349253692 |
21 | T>R | No |
ClinGen ExAC TOPMed gnomAD |
|
rs1458623915 CA349253686 |
22 | A>G | No |
ClinGen gnomAD |
|
rs755401292 CA1949272 |
23 | A>V | No |
ClinGen ExAC TOPMed gnomAD |
|
CA1949264 rs751683808 |
28 | P>A | No |
ClinGen ExAC gnomAD |
|
rs766564588 CA1949263 |
29 | A>S | No |
ClinGen ExAC |
|
rs966503981 CA60478713 |
31 | A>V | No |
ClinGen TOPMed |
|
CA349253634 rs1475321276 |
32 | T>A | No |
ClinGen TOPMed |
|
CA349253610 rs1341491428 |
36 | A>T | No |
ClinGen Ensembl |
|
CA349253604 rs1289326148 |
37 | P>S | No |
ClinGen TOPMed |
|
rs893597474 CA60478710 |
39 | A>V | No |
ClinGen TOPMed gnomAD |
|
CA349253582 rs1357516694 |
40 | P>L | No |
ClinGen TOPMed |
|
rs200509268 CA60478708 |
41 | A>P | No |
ClinGen Ensembl |
|
rs1288010117 CA349253572 |
42 | A>G | No |
ClinGen TOPMed |
|
rs1241658118 CA349253569 |
43 | P>A | No |
ClinGen TOPMed |
|
rs1353134476 CA349253567 |
43 | P>Q | No |
ClinGen gnomAD |
|
CA60478707 rs1001841887 |
46 | A>T | No |
ClinGen TOPMed |
|
CA60478706 rs906192180 |
48 | A>P | No |
ClinGen TOPMed |
|
CA349253540 rs906192180 |
48 | A>S | No |
ClinGen TOPMed |
|
CA60478705 rs1046616737 |
50 | A>P | No |
ClinGen TOPMed |
|
CA349253509 rs1311218706 |
53 | A>S | No |
ClinGen gnomAD |
|
CA349253506 rs1377642110 |
53 | A>V | No |
ClinGen TOPMed gnomAD |
|
rs1339842885 CA349253502 |
54 | V>D | No |
ClinGen gnomAD |
|
rs1240752153 CA349253503 |
54 | V>F | No |
ClinGen gnomAD |
|
CA349253498 rs765358308 |
55 | G>C | No |
ClinGen ExAC TOPMed gnomAD |
|
CA1949257 rs765358308 |
55 | G>S | No |
ClinGen ExAC TOPMed gnomAD |
|
rs1402310727 CA349253486 |
56 | W>C | No |
ClinGen gnomAD |
|
CA349253483 rs1297124211 |
57 | P>S | No |
ClinGen gnomAD |
|
rs760545362 CA1949256 |
59 | C>F | No |
ClinGen ExAC gnomAD |
|
rs1266405443 CA349253454 |
61 | D>G | No |
ClinGen TOPMed |
|
CA60478703 rs908699963 |
63 | Y>F | No |
ClinGen TOPMed |
|
rs1160865296 CA349253443 |
63 | Y>H | No |
ClinGen gnomAD |
|
rs1368455704 CA349253430 |
64 | E>D | No |
ClinGen gnomAD |
|
CA349253437 rs1440842849 |
64 | E>K | No |
ClinGen TOPMed gnomAD |
|
CA349253436 rs1440842849 |
64 | E>Q | No |
ClinGen TOPMed gnomAD |
|
CA349253420 rs1186069176 |
66 | Q>R | No |
ClinGen gnomAD |
|
rs1574593403 CA349253403 |
68 | V>G | No |
ClinGen Ensembl |
|
CA349253400 rs1168047946 |
69 | I>F | No |
ClinGen TOPMed |
|
rs1193098128 CA349252923 |
70 | G>D | No |
ClinGen gnomAD |
|
TCGA novel | 70 | G>S | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
CA349252921 rs1476964044 |
71 | S>G | No |
ClinGen gnomAD |
|
TCGA novel | 80 | A>T | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
rs202247725 CA349252858 |
81 | L>I | No |
ClinGen ExAC TOPMed gnomAD |
|
rs1450758561 CA349252844 |
83 | K>E | No |
ClinGen TOPMed gnomAD |
|
CA349252845 rs1450758561 |
83 | K>Q | No |
ClinGen TOPMed gnomAD |
|
rs200276483 CA60471233 |
84 | P>L | No |
ClinGen gnomAD |
|
rs1287509646 CA349252837 |
84 | P>S | No |
ClinGen gnomAD |
|
rs201828648 CA60471232 |
85 | R>G | No |
ClinGen Ensembl |
|
rs1216318729 CA349252814 |
87 | E>G | No |
ClinGen gnomAD |
|
CA349252817 rs1256864510 |
87 | E>Q | No |
ClinGen gnomAD |
|
CA60471231 rs201006515 |
88 | R>C | No |
ClinGen gnomAD |
|
COSM377583 COSM377584 rs370455370 CA1949242 |
88 | R>H | lung [Cosmic] | No |
ClinGen cosmic curated ESP ExAC gnomAD |
CA60471229 rs199899584 |
90 | A>V | No |
ClinGen Ensembl |
|
rs758605523 CA1949240 |
91 | I>V | No |
ClinGen ExAC gnomAD |
|
CA60471227 rs201730893 |
93 | R>Q | No |
ClinGen Ensembl |
|
CA60471228 rs769314682 |
93 | R>W | No |
ClinGen Ensembl |
|
CA349252767 rs1407541843 |
95 | N>S | No |
ClinGen TOPMed gnomAD |
|
TCGA novel | 98 | K>N | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
rs201221907 CA1949239 |
100 | Q>R | No |
ClinGen ExAC TOPMed gnomAD |
|
rs1464080076 CA349252714 |
102 | S>N | No |
ClinGen gnomAD |
|
CA349252710 rs1425882337 |
103 | M>V | No |
ClinGen gnomAD |
|
CA60471223 rs954473269 |
104 | D>E | No |
ClinGen TOPMed |
|
rs1187292608 CA349252702 |
104 | D>H | No |
ClinGen TOPMed gnomAD |
|
rs1187292608 CA349252701 |
104 | D>N | No |
ClinGen TOPMed gnomAD |
|
CA349252287 rs1280232976 |
108 | K>E | No |
ClinGen gnomAD |
|
CA349252267 rs1219457311 |
110 | I>S | No |
ClinGen gnomAD |
|
rs995248971 CA60469592 |
111 | Q>R | No |
ClinGen Ensembl |
|
rs1309017650 CA349252251 |
113 | M>V | No |
ClinGen gnomAD |
|
rs199693195 CA1949216 COSM1009065 COSM1009064 |
121 | V>I | Variant assessed as Somatic; 0.0 impact. endometrium [NCI-TCGA, Cosmic] | No |
ClinGen cosmic curated ESP ExAC NCI-TCGA TOPMed gnomAD |
rs1447312073 CA349252175 |
123 | T>N | No |
ClinGen gnomAD |
|
rs1357505871 CA349252163 |
125 | Y>H | No |
ClinGen gnomAD |
|
CA349252149 rs1294758361 |
127 | S>T | No |
ClinGen gnomAD |
|
rs201746945 CA60469591 |
135 | W>R | No |
ClinGen Ensembl |
|
rs1433759725 CA349252068 |
138 | M>I | No |
ClinGen gnomAD |
|
rs1286074971 CA349252008 |
145 | S>* | No |
ClinGen gnomAD |
|
TCGA novel | 145 | S>L | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
CA349252006 rs1415590857 |
146 | M>V | No |
ClinGen TOPMed gnomAD |
|
CA1949206 rs747479174 |
149 | I>V | No |
ClinGen ExAC gnomAD |
|
CA349251917 rs1574517653 |
152 | Y>N | No |
ClinGen Ensembl |
|
CA349251898 rs1296099523 |
153 | I>V | No |
ClinGen TOPMed gnomAD |
|
rs772371090 CA1949204 |
156 | R>* | No |
ClinGen ExAC TOPMed gnomAD |
|
rs376136352 CA349251843 |
156 | R>L | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
rs376136352 COSM1009060 COSM1009061 CA1949203 |
156 | R>Q | Variant assessed as Somatic; 0.0 impact. endometrium [NCI-TCGA, Cosmic] | No |
ClinGen cosmic curated ESP ExAC NCI-TCGA TOPMed gnomAD |
CA60469252 rs202246318 |
159 | H>Q | No |
ClinGen TOPMed |
|
TCGA novel | 160 | K>N | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
rs757491102 CA349251765 |
161 | N>I | No |
ClinGen ExAC TOPMed gnomAD |
|
CA1949201 rs757491102 |
161 | N>S | No |
ClinGen ExAC TOPMed gnomAD |
|
CA349251740 rs1477288860 |
163 | V>F | No |
ClinGen gnomAD |
|
CA349251744 rs1477288860 |
163 | V>I | No |
ClinGen gnomAD |
|
TCGA novel | 164 | L>P | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
CA349251688 rs1261697990 |
167 | A>E | No |
ClinGen gnomAD |
|
TCGA novel | 167 | A>G | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
rs200991167 CA1949199 |
167 | A>T | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
COSM571143 rs756179998 CA1949198 |
168 | I>V | lung Variant assessed as Somatic; 0.0 impact. [Cosmic, NCI-TCGA] | No |
ClinGen cosmic curated ExAC NCI-TCGA gnomAD |
rs751493627 CA1949197 |
170 | A>S | No |
ClinGen ExAC gnomAD |
|
rs1405632029 CA349251664 |
171 | T>I | No |
ClinGen TOPMed |
|
CA1949196 rs200424635 |
172 | I>V | No |
ClinGen ExAC gnomAD |
|
CA60469250 rs375334316 |
174 | K>R | No |
ClinGen ESP |
|
TCGA novel | 175 | E>Q | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
CA349251593 rs1477612129 |
181 | D>E | No |
ClinGen TOPMed gnomAD |
|
CA60469248 COSM1305822 rs201338418 COSM1305821 |
182 | Y>C | lung NS urinary_tract [Cosmic] | No |
ClinGen cosmic curated TOPMed |
CA349251561 rs1339950448 |
186 | N>S | No |
ClinGen gnomAD |
|
CA349251557 rs201684592 |
187 | G>C | No |
ClinGen ExAC gnomAD |
|
COSM1266944 COSM1266945 CA1949194 rs201684592 |
187 | G>S | Variant assessed as Somatic; 0.0 impact. oesophagus [NCI-TCGA, Cosmic] | No |
ClinGen cosmic curated ExAC NCI-TCGA gnomAD |
CA349251550 rs1311483244 |
188 | Q>E | Variant assessed as Somatic; impact. [NCI-TCGA] | No |
ClinGen NCI-TCGA TOPMed |
rs1357790058 CA349251528 |
190 | H>R | No |
ClinGen TOPMed |
|
TCGA novel | 191 | R>M | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
CA349251319 rs1300329889 |
198 | I>F | No |
ClinGen TOPMed gnomAD |
|
rs1300329889 CA349251320 |
198 | I>V | No |
ClinGen TOPMed gnomAD |
|
rs1330422220 CA349254745 |
214 | S>R | No |
ClinGen gnomAD |
|
rs1174705830 CA349254739 |
215 | A>V | No |
ClinGen TOPMed gnomAD |
|
rs200906112 CA60466707 |
221 | G>A | No |
ClinGen ExAC gnomAD |
|
CA1949156 rs200906112 |
221 | G>D | No |
ClinGen ExAC gnomAD |
|
CA1949157 rs200257510 |
221 | G>S | No |
ClinGen 1000Genomes ExAC TOPMed gnomAD |
|
CA60466705 rs200027661 |
225 | R>* | No |
ClinGen TOPMed gnomAD |
|
CA60466706 rs200027661 |
225 | R>G | No |
ClinGen TOPMed gnomAD |
|
rs1486798835 CA349254643 |
231 | T>A | No |
ClinGen gnomAD |
|
rs745760424 CA1949154 |
233 | V>I | No |
ClinGen ExAC gnomAD |
|
rs1351251071 CA349254622 |
234 | G>D | No |
ClinGen gnomAD |
|
CA60466704 rs201333511 COSM1726454 COSM1726455 |
239 | M>I | liver [Cosmic] | No |
ClinGen cosmic curated Ensembl |
CA349254539 rs1574496975 |
246 | Q>K | No |
ClinGen Ensembl |
|
CA1949130 rs749264154 |
248 | R>I | No |
ClinGen ExAC gnomAD |
|
rs755937393 CA1949128 |
250 | Y>C | No |
ClinGen ExAC gnomAD |
|
rs777480578 CA1949129 |
250 | Y>D | No |
ClinGen ExAC gnomAD |
|
TCGA novel | 253 | K>N | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
CA349254467 rs1193722367 |
254 | A>S | No |
ClinGen gnomAD |
|
CA349254421 rs1284277301 |
260 | G>R | No |
ClinGen gnomAD |
|
CA349254403 rs1374535691 |
262 | T>I | No |
ClinGen gnomAD |
|
CA349254371 rs1265109083 |
267 | A>V | No |
ClinGen TOPMed gnomAD |
|
CA1949125 rs754666662 |
271 | A>V | No |
ClinGen ExAC TOPMed gnomAD |
|
CA1949123 rs765973701 |
274 | H>Y | No |
ClinGen ExAC gnomAD |
|
CA349254321 rs1216378830 |
275 | K>R | No |
ClinGen gnomAD |
|
rs763308836 CA1949122 |
279 | M>I | No |
ClinGen ExAC TOPMed gnomAD |
|
rs901718939 CA60466684 |
280 | K>T | No |
ClinGen TOPMed |
|
CA60466463 rs916396480 |
283 | M>V | No |
ClinGen Ensembl |
|
rs1414143514 CA349254203 |
290 | P>A | No |
ClinGen gnomAD |
|
CA1949102 rs757876668 |
296 | G>R | No |
ClinGen ExAC gnomAD |
|
rs372899334 CA1949099 |
297 | V>L | No |
ClinGen ESP ExAC gnomAD |
|
rs369314671 CA1949098 |
298 | E>K | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
rs1460414130 CA349254145 |
299 | D>A | No |
ClinGen TOPMed |
|
TCGA novel | 301 | E>* | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
CA1949096 rs767450815 |
302 | M>I | No |
ClinGen ExAC gnomAD |
|
rs775815629 CA1949097 |
302 | M>T | No |
ClinGen ExAC gnomAD |
|
rs558024642 CA1949094 |
307 | G>S | No |
ClinGen 1000Genomes ExAC gnomAD |
|
TCGA novel | 308 | K>S | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
COSM134043 rs1285852195 CA349254047 |
311 | R>K | skin [Cosmic] | No |
ClinGen cosmic curated gnomAD |
TCGA novel | 312 | K>* | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
rs1258618607 CA349254028 |
312 | K>I | No |
ClinGen TOPMed gnomAD |
|
TCGA novel | 320 | K>N | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
CA1949091 rs776354325 |
321 | D>E | No |
ClinGen ExAC TOPMed gnomAD |
|
rs746601162 CA1949089 |
324 | K>R | No |
ClinGen ExAC gnomAD |
|
rs771748371 CA1949068 |
327 | T>R | No |
ClinGen ExAC gnomAD |
|
CA60465558 rs780056867 |
330 | E>K | No |
ClinGen TOPMed gnomAD |
|
rs1559111375 CA349253174 |
332 | L>I | No |
ClinGen Ensembl |
|
TCGA novel | 334 | C>* | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
rs911069836 CA349253159 |
334 | C>R | No |
ClinGen TOPMed gnomAD |
|
CA349253156 rs1164014837 |
334 | C>S | No |
ClinGen gnomAD |
|
rs911069836 CA60465557 |
334 | C>S | No |
ClinGen TOPMed gnomAD |
|
rs745570599 CA1949067 |
335 | K>Q | No |
ClinGen ExAC gnomAD |
|
rs747145300 CA60465556 |
335 | K>R | No |
ClinGen Ensembl |
|
CA349253108 rs1419431156 |
341 | K>E | No |
ClinGen gnomAD |
|
rs1559111273 CA349253086 |
342 | N>H | No |
ClinGen Ensembl |
|
CA349253060 rs1275285562 |
345 | Y>C | No |
ClinGen Ensembl |
|
rs1370925630 CA349253064 |
345 | Y>N | No |
ClinGen gnomAD |
|
CA349253047 rs1430623118 |
347 | I>T | No |
ClinGen gnomAD |
|
rs1193531417 CA349253009 |
353 | R>K | No |
ClinGen gnomAD |
|
rs1802105 CA60465549 |
354 | T>P | No |
ClinGen Ensembl |
|
rs1214463284 CA349252998 |
355 | P>A | No |
ClinGen gnomAD |
|
CA349252994 rs1480358504 |
355 | P>L | No |
ClinGen gnomAD |
|
rs764061473 CA1949054 |
356 | D>A | No |
ClinGen ExAC TOPMed gnomAD |
|
CA349252990 rs764061473 |
356 | D>G | No |
ClinGen ExAC TOPMed gnomAD |
|
CA1949052 rs775341343 |
357 | I>V | No |
ClinGen ExAC TOPMed gnomAD |
|
rs1426461901 CA349252958 |
361 | A>P | No |
ClinGen TOPMed |
|
TCGA novel | 361 | A>T | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
rs201077678 CA1949040 |
365 | R>K | No |
ClinGen ExAC TOPMed gnomAD |
|
CA1949038 rs750511524 |
369 | G>E | No |
ClinGen ExAC TOPMed gnomAD |
|
TCGA novel | 372 | G>V | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
CA1949037 rs765291388 |
373 | H>R | No |
ClinGen ExAC TOPMed gnomAD |
|
rs752579447 CA349252586 |
375 | H>L | No |
ClinGen ExAC gnomAD |
|
CA1949035 rs752579447 |
375 | H>R | No |
ClinGen ExAC gnomAD |
|
CA60459513 rs980414959 |
376 | K>E | No |
ClinGen gnomAD |
|
rs759384781 CA1949033 |
378 | E>K | No |
ClinGen ExAC TOPMed gnomAD |
|
rs1362104547 CA349252554 |
380 | G>R | No |
ClinGen gnomAD |
|
rs768321414 CA60459512 |
381 | D>G | No |
ClinGen TOPMed |
|
rs1333451147 CA349252547 |
381 | D>N | No |
ClinGen TOPMed |
|
rs1419883596 CA349252526 |
383 | E>D | No |
ClinGen gnomAD |
|
TCGA novel | 383 | E>missing | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
CA349252512 rs1195351394 |
385 | S>N | No |
ClinGen TOPMed gnomAD |
|
CA349252502 rs1186114001 |
386 | D>G | No |
ClinGen gnomAD |
|
rs769195080 CA1949028 |
387 | D>G | No |
ClinGen ExAC gnomAD |
|
CA1949029 rs772724891 |
387 | D>N | No |
ClinGen ExAC TOPMed gnomAD |
|
CA349252493 rs1345491124 |
388 | E>K | No |
ClinGen TOPMed |
|
rs1239064986 CA349252482 |
389 | M>T | No |
ClinGen gnomAD |
|
rs777023649 CA1949026 |
389 | M>V | No |
ClinGen ExAC gnomAD |
|
rs769197906 CA1949025 |
390 | D>N | No |
ClinGen ExAC gnomAD |
|
rs747339900 CA1949024 |
390 | D>V | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen ExAC NCI-TCGA gnomAD |
rs780458695 CA1949023 |
391 | E>Q | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen ExAC NCI-TCGA TOPMed gnomAD |
rs1357740688 CA349252458 |
392 | K>N | No |
ClinGen gnomAD |
|
CA1949022 rs201100288 |
393 | S>N | No |
ClinGen ExAC TOPMed gnomAD |
|
rs199943116 CA1949020 |
394 | E>K | No |
ClinGen ExAC TOPMed gnomAD |
|
rs754000627 CA1949018 |
398 | A>T | No |
ClinGen ExAC TOPMed gnomAD |
|
rs767531913 CA1949017 |
398 | A>V | No |
ClinGen ExAC gnomAD |
|
rs56031549 CA1949016 |
399 | A>T | No |
ClinGen 1000Genomes ESP ExAC TOPMed gnomAD |
|
CA1949015 rs751387128 |
401 | S>P | No |
ClinGen ExAC TOPMed gnomAD |
|
CA349252390 rs1192275725 |
403 | E>K | No |
ClinGen gnomAD |
|
CA349252376 rs56697518 |
404 | K>N | No |
ClinGen 1000Genomes ESP ExAC TOPMed gnomAD |
|
rs753329037 CA1948989 |
406 | R>G | No |
ClinGen ExAC gnomAD |
|
CA1948988 rs763607390 |
406 | R>Q | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen ExAC NCI-TCGA gnomAD |
rs947669343 CA60459504 |
407 | R>K | No |
ClinGen Ensembl |
|
CA349252349 rs1272326865 |
407 | R>S | No |
ClinGen gnomAD |
|
CA349252345 rs1459459172 |
408 | V>A | No |
ClinGen TOPMed |
|
rs201915974 CA60459503 |
408 | V>I | No |
ClinGen TOPMed gnomAD |
|
CA349252321 rs1301896796 |
411 | E>D | No |
ClinGen TOPMed gnomAD |
|
rs992358171 CA60459502 |
411 | E>Q | No |
ClinGen Ensembl |
|
CA1948986 rs776007211 |
413 | P>T | No |
ClinGen ExAC gnomAD |
|
CA1948985 rs369988565 |
414 | E>K | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
rs376856499 CA1948967 |
415 | I>V | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
TCGA novel | 417 | V>L | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
CA349251493 rs1186816829 |
418 | S>G | No |
ClinGen gnomAD |
|
rs767907261 CA1948966 |
420 | S>R | No |
ClinGen ExAC gnomAD |
|
CA1948962 rs187318954 |
425 | Q>P | No |
ClinGen 1000Genomes ExAC gnomAD |
|
rs967406185 CA60458399 |
426 | I>M | No |
ClinGen TOPMed |
|
rs1222091118 CA349251429 |
427 | Q>P | No |
ClinGen gnomAD |
|
CA60458398 rs371286172 |
429 | L>V | No |
ClinGen ESP TOPMed |
|
CA349251410 rs773594176 |
430 | S>C | No |
ClinGen ExAC TOPMed gnomAD |
|
CA1948960 rs773594176 |
430 | S>F | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen ExAC NCI-TCGA TOPMed gnomAD |
CA349251406 rs1227540627 |
431 | V>A | No |
ClinGen TOPMed |
|
CA1948959 rs770193318 |
431 | V>L | No |
ClinGen ExAC gnomAD |
|
rs748206003 CA1948958 |
432 | H>D | No |
ClinGen ExAC gnomAD |
|
CA1948956 rs771887076 |
433 | D>A | No |
ClinGen ExAC TOPMed gnomAD |
|
CA349251397 rs1314561370 |
433 | D>N | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen NCI-TCGA gnomAD |
CA60458397 rs953426929 |
434 | S>C | No |
ClinGen TOPMed |
|
rs745827456 CA1948955 |
434 | S>P | No |
ClinGen ExAC TOPMed gnomAD |
|
CA1948937 COSM1400976 COSM1400977 rs776513083 |
438 | P>H | Variant assessed as Somatic; 0.0 impact. large_intestine [NCI-TCGA, Cosmic] | No |
ClinGen cosmic curated ExAC NCI-TCGA gnomAD |
CA349251212 rs776513083 |
438 | P>L | No |
ClinGen ExAC gnomAD |
|
rs905930426 CA60458211 |
439 | N>D | No |
ClinGen TOPMed gnomAD |
|
CA60458212 rs905930426 |
439 | N>H | No |
ClinGen TOPMed gnomAD |
|
rs183634219 CA1948934 |
439 | N>S | No |
ClinGen 1000Genomes ExAC TOPMed gnomAD |
|
rs183634219 CA1948935 |
439 | N>T | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen 1000Genomes ExAC NCI-TCGA TOPMed gnomAD |
CA349251204 rs1419280954 |
440 | A>S | No |
ClinGen gnomAD |
|
CA349251200 rs1185254919 |
441 | N>D | No |
ClinGen gnomAD |
|
rs942822043 CA60458210 |
441 | N>I | No |
ClinGen TOPMed |
|
CA349251197 rs942822043 |
441 | N>S | No |
ClinGen TOPMed |
|
CA1948932 rs553932507 |
442 | E>D | No |
ClinGen ExAC TOPMed gnomAD |
|
CA1948931 rs201012106 |
443 | D>Y | No |
ClinGen 1000Genomes ExAC TOPMed gnomAD |
|
CA349251178 rs1213082386 |
444 | Y>D | No |
ClinGen TOPMed gnomAD |
|
rs1467197996 CA349251171 |
445 | R>G | No |
ClinGen TOPMed gnomAD |
|
rs755705794 CA1948930 |
445 | R>K | No |
ClinGen ExAC gnomAD |
|
CA349251160 rs1222614397 |
446 | E>V | No |
ClinGen gnomAD |
|
rs200072066 CA1948929 |
448 | S>A | No |
ClinGen ExAC gnomAD |
|
rs191390185 CA1948928 |
448 | S>Y | No |
ClinGen 1000Genomes ExAC TOPMed gnomAD |
|
CA349251143 rs1365913790 |
449 | S>F | No |
ClinGen gnomAD |
|
CA1948927 rs201894497 |
449 | S>P | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
CA1948925 rs766882116 |
450 | C>S | No |
ClinGen ExAC gnomAD |
|
rs371452650 CA1948924 |
450 | C>Y | No |
ClinGen 1000Genomes ESP ExAC TOPMed gnomAD |
|
rs750801957 CA1948923 |
451 | A>V | No |
ClinGen ExAC gnomAD |
|
rs762057185 CA1948921 |
452 | V>M | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen ExAC NCI-TCGA TOPMed gnomAD |
CA349251124 rs1443458443 |
453 | N>D | No |
ClinGen TOPMed |
|
CA349251117 rs1559079429 |
454 | L>V | No |
ClinGen Ensembl |
|
CA1948919 rs764031679 |
455 | V>I | No |
ClinGen ExAC gnomAD |
|
CA349254044 rs1197564622 |
460 | N>D | No |
ClinGen TOPMed gnomAD |
|
CA1948903 rs754201506 |
460 | N>S | No |
ClinGen ExAC gnomAD |
|
TCGA novel | 463 | K>N | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
rs764344658 CA1948902 |
463 | K>R | No |
ClinGen ExAC TOPMed gnomAD |
|
CA349253971 rs1256833444 |
465 | L>P | No |
ClinGen Ensembl |
|
rs760864948 CA1948901 |
466 | N>S | No |
ClinGen ExAC gnomAD |
|
rs753362711 COSM3670298 CA60453039 COSM3670299 |
469 | R>* | central_nervous_system [Cosmic] | No |
ClinGen cosmic curated Ensembl |
rs1483235189 CA349253946 |
469 | R>Q | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen NCI-TCGA gnomAD |
CA1948899 rs200294746 |
471 | E>Q | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
CA1948897 rs773159718 |
474 | P>S | No |
ClinGen ExAC gnomAD |
|
CA1948896 rs769776880 |
475 | G>R | No |
ClinGen ExAC gnomAD |
|
rs761639622 CA1948895 |
476 | R>G | No |
ClinGen ExAC TOPMed gnomAD |
|
rs1300472813 CA349253374 |
478 | T>A | No |
ClinGen TOPMed |
|
rs1242984484 CA349253352 |
481 | G>D | No |
ClinGen gnomAD |
|
CA349253349 rs1342669862 |
482 | V>I | No |
ClinGen gnomAD |
|
rs767537417 CA1948877 |
493 | D>G | No |
ClinGen ExAC gnomAD |
|
CA349253262 rs1386509212 |
495 | H>Y | No |
ClinGen gnomAD |
|
rs1457844606 CA349253255 |
496 | D>N | No |
ClinGen gnomAD |
|
rs775463188 CA1948852 |
501 | A>G | No |
ClinGen ExAC gnomAD |
|
rs767274202 CA1948851 |
502 | A>G | No |
ClinGen ExAC TOPMed gnomAD |
|
CA60447212 rs767274202 |
502 | A>V | No |
ClinGen ExAC TOPMed gnomAD |
|
CA349250589 rs1574349451 |
504 | L>F | No |
ClinGen Ensembl |
|
rs1259486917 CA349250586 |
505 | Q>* | No |
ClinGen TOPMed |
|
CA349250558 rs1195518300 |
509 | D>H | No |
ClinGen gnomAD |
|
rs935846655 CA60447211 |
513 | A>T | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen NCI-TCGA gnomAD |
rs199600350 COSM1400973 CA1948850 COSM1400972 |
513 | A>V | Variant assessed as Somatic; 0.0 impact. large_intestine [NCI-TCGA, Cosmic] | No |
ClinGen cosmic curated ESP ExAC NCI-TCGA TOPMed gnomAD |
CA1948834 rs779099780 |
522 | A>S | No |
ClinGen ExAC TOPMed gnomAD |
|
CA349251961 rs1260602424 |
524 | G>V | No |
ClinGen TOPMed |
|
CA1948832 rs541206860 |
525 | C>F | No |
ClinGen 1000Genomes ExAC TOPMed gnomAD |
|
TCGA novel | 525 | C>R | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
CA60446199 rs541206860 |
525 | C>S | No |
ClinGen 1000Genomes ExAC TOPMed gnomAD |
|
rs541206860 CA1948833 |
525 | C>Y | No |
ClinGen 1000Genomes ExAC TOPMed gnomAD |
|
rs751196398 CA1948831 |
526 | D>N | No |
ClinGen ExAC gnomAD |
|
CA1948830 rs762341266 |
528 | S>L | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen ExAC NCI-TCGA TOPMed gnomAD |
rs762341266 CA1948829 |
528 | S>W | No |
ClinGen ExAC TOPMed gnomAD |
|
CA349251902 rs1283704632 |
529 | E>D | No |
ClinGen gnomAD |
|
rs776910728 CA1948825 |
535 | K>R | No |
ClinGen ExAC gnomAD |
|
CA349251815 rs1158204214 |
537 | I>T | Variant assessed as Somatic; impact. [NCI-TCGA] | No |
ClinGen NCI-TCGA TOPMed |
CA60446198 rs999421278 |
539 | F>S | No |
ClinGen gnomAD |
|
CA349251771 rs1285856193 |
541 | Q>* | No |
ClinGen gnomAD |
|
rs1344086024 CA349251751 |
542 | L>F | No |
ClinGen gnomAD |
|
TCGA novel | 542 | L>S | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
CA349251753 rs1238519102 |
542 | L>W | No |
ClinGen gnomAD |
|
CA349251710 rs1318020616 |
545 | S>R | No |
ClinGen gnomAD |
No associated diseases with Q9UEW8
Functions
Description | ||
---|---|---|
EC Number | 2.7.11.1 | Protein-serine/threonine kinases |
Subcellular Localization |
|
|
PANTHER Family | ||
PANTHER Subfamily | ||
PANTHER Protein Class | ||
PANTHER Pathway Category | No pathway information available |
9 GO annotations of cellular component
Name | Definition |
---|---|
apical plasma membrane | The region of the plasma membrane located at the apical end of the cell. |
basolateral plasma membrane | The region of the plasma membrane that includes the basal end and sides of the cell. Often used in reference to animal polarized epithelial membranes, where the basal membrane is the part attached to the extracellular matrix, or in plant cells, where the basal membrane is defined with respect to the zygotic axis. |
cell body | The portion of a cell bearing surface projections such as axons, dendrites, cilia, or flagella that includes the nucleus, but excludes all cell projections. |
cytoplasm | The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
cytoskeleton | A cellular structure that forms the internal framework of eukaryotic and prokaryotic cells. The cytoskeleton includes intermediate filaments, microfilaments, microtubules, the microtrabecular lattice, and other structures characterized by a polymeric filamentous nature and long-range order within the cell. The various elements of the cytoskeleton not only serve in the maintenance of cellular shape but also have roles in other cellular functions, including cellular movement, cell division, endocytosis, and movement of organelles. |
cytosol | The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. |
extrinsic component of membrane | The component of a membrane consisting of gene products and protein complexes that are loosely bound to one of its surfaces, but not integrated into the hydrophobic region. |
intracellular membrane-bounded organelle | Organized structure of distinctive morphology and function, bounded by a single or double lipid bilayer membrane and occurring within the cell. Includes the nucleus, mitochondria, plastids, vacuoles, and vesicles. Excludes the plasma membrane. |
nucleoplasm | That part of the nuclear content other than the chromosomes or the nucleolus. |
5 GO annotations of molecular function
Name | Definition |
---|---|
ATP binding | Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator. |
kinase activity | Catalysis of the transfer of a phosphate group, usually from ATP, to a substrate molecule. |
protein kinase binding | Binding to a protein kinase, any enzyme that catalyzes the transfer of a phosphate group, usually from ATP, to a protein substrate. |
protein serine kinase activity | Catalysis of the reactions: ATP + protein serine = ADP + protein serine phosphate. |
protein serine/threonine kinase activity | Catalysis of the reactions: ATP + protein serine = ADP + protein serine phosphate, and ATP + protein threonine = ADP + protein threonine phosphate. |
28 GO annotations of biological process
Name | Definition |
---|---|
cellular chloride ion homeostasis | Any process involved in the maintenance of an internal steady state of chloride ions at the level of a cell. |
cellular hypotonic response | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of detection of, or exposure to, a hypotonic environment, i.e. an environment with a lower concentration of solutes than the organism or cell. |
cellular response to chemokine | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a chemokine stimulus. |
cellular response to potassium ion | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a potassium ion stimulus. |
chemokine (C-X-C motif) ligand 12 signaling pathway | The series of molecular signals initiated by the binding of the chemokine CXCL12 to its receptor on the surface of a target cell, and ending with the regulation of a downstream cellular process, e.g. transcription. |
inflammatory response | The immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents. The process is characterized by local vasodilation, extravasation of plasma into intercellular spaces and accumulation of white blood cells and macrophages. |
intracellular signal transduction | The process in which a signal is passed on to downstream components within the cell, which become activated themselves to further propagate the signal and finally trigger a change in the function or state of the cell. |
macrophage activation | A change in morphology and behavior of a macrophage resulting from exposure to a cytokine, chemokine, cellular ligand, or soluble factor. |
maintenance of lens transparency | A homeostatic process in which the lens is maintained in a highly refractive, transparent state to allow for optimal focusing of light on the retina. |
negative regulation of creatine transmembrane transporter activity | Any process that stops, prevents or reduces the frequency, rate or extent of creatine transmembrane transporter activity. |
negative regulation of pancreatic juice secretion | Any process that decreases the rate, frequency or extent of pancreatic juice secretion, the regulated release of pancreatic juice by the exocrine pancreas into the upper part of the intestine. |
negative regulation of potassium ion transmembrane transport | Any process that stops, prevents or reduces the frequency, rate or extent of potassium ion transmembrane transport. |
negative regulation of potassium ion transmembrane transporter activity | Any process that stops, prevents or reduces the frequency, rate or extent of potassium ion transmembrane transporter activity. |
negative regulation of sodium ion transmembrane transporter activity | Any process that stops, prevents or reduces the frequency, rate or extent of sodium ion transmembrane transporter activity. |
peptidyl-serine phosphorylation | The phosphorylation of peptidyl-serine to form peptidyl-O-phospho-L-serine. |
peptidyl-threonine phosphorylation | The phosphorylation of peptidyl-threonine to form peptidyl-O-phospho-L-threonine. |
positive regulation of ion transmembrane transporter activity | Any process that activates or increases the activity of an ion transporter. |
positive regulation of p38MAPK cascade | Any process that activates or increases the frequency, rate or extent of p38MAPK cascade. |
positive regulation of potassium ion transport | Any process that activates or increases the frequency, rate or extent of the directed movement of potassium ions (K+) into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. |
positive regulation of T cell chemotaxis | Any process that increases the rate, frequency or extent of T cell chemotaxis. T cell chemotaxis is the directed movement of a T cell in response to an external stimulus. |
protein autophosphorylation | The phosphorylation by a protein of one or more of its own amino acid residues (cis-autophosphorylation), or residues on an identical protein (trans-autophosphorylation). |
protein phosphorylation | The process of introducing a phosphate group on to a protein. |
regulation of blood pressure | Any process that modulates the force with which blood travels through the circulatory system. The process is controlled by a balance of processes that increase pressure and decrease pressure. |
regulation of inflammatory response | Any process that modulates the frequency, rate or extent of the inflammatory response, the immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents. |
response to aldosterone | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an aldosterone stimulus. |
response to dietary excess | The physiological process in which dietary excess is sensed by the central nervous system, resulting in a reduction in food intake and increased energy expenditure. |
signal transduction | The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell. |
sodium ion transmembrane transport | A process in which a sodium ion is transported from one side of a membrane to the other by means of some agent such as a transporter or pore. |
20 homologous proteins in AiPD
UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
---|---|---|---|---|
Q9C0K7 | STRADB | STE20-related kinase adapter protein beta | Homo sapiens (Human) | PR |
Q7RTN6 | STRADA | STE20-related kinase adapter protein alpha | Homo sapiens (Human) | PR |
Q9H2G2 | SLK | STE20-like serine/threonine-protein kinase | Homo sapiens (Human) | PR |
O94804 | STK10 | Serine/threonine-protein kinase 10 | Homo sapiens (Human) | PR |
O95747 | OXSR1 | Serine/threonine-protein kinase OSR1 | Homo sapiens (Human) | PR |
Q9Y4K4 | MAP4K5 | Mitogen-activated protein kinase kinase kinase kinase 5 | Homo sapiens (Human) | PR |
Q92918 | MAP4K1 | Mitogen-activated protein kinase kinase kinase kinase 1 | Homo sapiens (Human) | EV |
Q12851 | MAP4K2 | Mitogen-activated protein kinase kinase kinase kinase 2 | Homo sapiens (Human) | EV |
Q8IVH8 | MAP4K3 | Mitogen-activated protein kinase kinase kinase kinase 3 | Homo sapiens (Human) | SS |
Q9P289 | STK26 | Serine/threonine-protein kinase 26 | Homo sapiens (Human) | PR |
Q9Y6E0 | STK24 | Serine/threonine-protein kinase 24 | Homo sapiens (Human) | PR |
O00506 | STK25 | Serine/threonine-protein kinase 25 | Homo sapiens (Human) | PR |
Q8K4T3 | Stradb | STE20-related kinase adapter protein beta | Mus musculus (Mouse) | PR |
Q3UUJ4 | Strada | STE20-related kinase adapter protein alpha | Mus musculus (Mouse) | PR |
Q6P9R2 | Oxsr1 | Serine/threonine-protein kinase OSR1 | Mus musculus (Mouse) | PR |
Q9Z1W9 | Stk39 | STE20/SPS1-related proline-alanine-rich protein kinase | Mus musculus (Mouse) | PR |
Q863I2 | OXSR1 | Serine/threonine-protein kinase OSR1 | Sus scrofa (Pig) | PR |
Q7TNZ6 | Strada | STE20-related kinase adapter protein alpha | Rattus norvegicus (Rat) | PR |
O88506 | Stk39 | STE20/SPS1-related proline-alanine-rich protein kinase | Rattus norvegicus (Rat) | PR |
O23304 | BLUS1 | Serine/threonine-protein kinase BLUS1 | Arabidopsis thaliana (Mouse-ear cress) | PR |
10 | 20 | 30 | 40 | 50 | 60 |
MAEPSGSPVH | VQLPQQAAPV | TAAAAAAPAA | ATAAPAPAAP | AAPAPAPAPA | AQAVGWPICR |
70 | 80 | 90 | 100 | 110 | 120 |
DAYELQEVIG | SGATAVVQAA | LCKPRQERVA | IKRINLEKCQ | TSMDELLKEI | QAMSQCSHPN |
130 | 140 | 150 | 160 | 170 | 180 |
VVTYYTSFVV | KDELWLVMKL | LSGGSMLDII | KYIVNRGEHK | NGVLEEAIIA | TILKEVLEGL |
190 | 200 | 210 | 220 | 230 | 240 |
DYLHRNGQIH | RDLKAGNILL | GEDGSVQIAD | FGVSAFLATG | GDVTRNKVRK | TFVGTPCWMA |
250 | 260 | 270 | 280 | 290 | 300 |
PEVMEQVRGY | DFKADMWSFG | ITAIELATGA | APYHKYPPMK | VLMLTLQNDP | PTLETGVEDK |
310 | 320 | 330 | 340 | 350 | 360 |
EMMKKYGKSF | RKLLSLCLQK | DPSKRPTAAE | LLKCKFFQKA | KNREYLIEKL | LTRTPDIAQR |
370 | 380 | 390 | 400 | 410 | 420 |
AKKVRRVPGS | SGHLHKTEDG | DWEWSDDEMD | EKSEEGKAAF | SQEKSRRVKE | ENPEIAVSAS |
430 | 440 | 450 | 460 | 470 | 480 |
TIPEQIQSLS | VHDSQGPPNA | NEDYREASSC | AVNLVLRLRN | SRKELNDIRF | EFTPGRDTAD |
490 | 500 | 510 | 520 | 530 | 540 |
GVSQELFSAG | LVDGHDVVIV | AANLQKIVDD | PKALKTLTFK | LASGCDGSEI | PDEVKLIGFA |
QLSVS |